论文部分内容阅读
目的:评价应用施他宁、善得定和生长激素治疗重症急性胰腺炎的疗效。方法:对1993年7月～2001年11月收治的21例应用施他宁、善得定和生长激素治疗的患者(观察组)进行回顾性分析,并与1991年10月～1995年3月收治的18例重症急性胰腺炎未用施他宁、善得定和生长激素治疗的患者(对照组)进行对照,观察两组治疗期间第1天、第3天、第7天APACHE(acutephysiology,and chronic health evaluation)Ⅱ评分的变化、住院日数、并发症、治愈率、死亡率、血淀粉酶恢复正常天数及主要症状的改善天数。结果:观察组能减少并发症,降低死亡率,缩短住院日数、血淀粉酶恢复天数及主要症状的改善天数。结论:施他宁、善得定和生长激素可能是较有效的治疗重症急性胰腺炎的药物。
OBJECTIVE: To evaluate the efficacy of the combination of Sitatron, Sedative and Growth Hormone in the treatment of severe acute pancreatitis. Methods: A retrospective analysis was performed on 21 patients (observation group) who were treated with shitadin, goodadine and growth hormone from July 1993 to November 2001, and were retrospectively analyzed from October 1991 to March 1995 18 cases of severe acute pancreatitis were treated with shituning, good set and growth hormone treatment of patients (control group) were compared to observe the two groups during the first day, day 3, day 7 APACHE (acutephysiology, and chronic health evaluation II scores, length of hospital stay, complications, cure rate, mortality, number of days for recovery of blood amylase and days of improvement of the main symptoms. Results: The observation group can reduce complications, reduce mortality, shorten the length of stay, the number of days of serum amylase recovery and the number of days to improve the main symptoms. CONCLUSIONS: Sitatin, Sedative and Growth Hormone may be more effective in the treatment of severe acute pancreatitis.